DNAHealthcareSmall-Cap
Ginkgo Bioworks Holdings, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Ginkgo Bioworks Holdings, Inc. (DNA), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are DNA insiders buying or selling?
Ginkgo Bioworks Holdings, Inc. insiders reported 4 open-market buys ($1.7M) and 353 sells ($193.3M) across 357 Form 4 filings — a net selling position of $191.5M.
Source: SEC EDGAR Form 4
Key Statistics (as of May 26, 2026)
Total Form 4 filings
357
SEC EDGAR
Insider filers
10
Insider buys (4)
$1.7M
Insider sells (353)
$193.3M
Insider sentiment
Net sellingNet insider flow of $191.5M in net selling.
Recent DNA insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 26, 2026 | Steven P. Coen | Chief Financial Officer | Sale | 307 | $8.33 | $2.6K |
| Apr 20, 2026 | Steven P. Coen | Chief Financial Officer | Sale | 324 | $7.95 | $2.6K |
| Apr 14, 2026 | Steven P. Coen | Chief Financial Officer | Sale | 33.2K | $6.41 | $212.8K |
| Apr 13, 2026 | Barry Canton | 10% Owner | Sale | 124.7K | $6.43 | $802.5K |
| Apr 13, 2026 | Reshma P. Shetty | President & Founder | Sale | 124.7K | $6.43 | $802.5K |
| Apr 10, 2026 | Reshma P. Shetty | President & Founder | Sale | 26.3K | $6.66 | $175.1K |
| Apr 10, 2026 | Barry Canton | 10% Owner | Sale | 26.3K | $6.66 | $175.1K |
| Apr 10, 2026 | Jason R Kelly | CEO & Founder | Sale | 206.8K | $6.65 | $1.4M |
| Mar 18, 2026 | Steven P. Coen | Chief Financial Officer | Sale | 708 | $6.74 | $4.8K |
| Jan 22, 2026 | Steven P. Coen | Chief Financial Officer | Sale | 972 | $8.92 | $8.7K |
| Dec 16, 2025 | Steven P. Coen | Chief Financial Officer | Sale | 736 | $8.89 | $6.5K |
| Oct 21, 2025 | Steven P. Coen | Chief Financial Officer | Sale | 1.3K | $13.65 | $17.9K |
| Oct 3, 2025 | Steven P. Coen | Chief Financial Officer | Sale | 5.6K | $15.00 | $84.1K |
| Sep 10, 2025 | Christian O Henry | Director | Sale | 20.0K | $10.99 | $219.8K |
| Aug 26, 2025 | Steven P. Coen | Chief Financial Officer | Sale | 310 | $12.40 | $3.8K |
| Jul 21, 2025 | Steven P. Coen | Chief Financial Officer and Chief Accounting Officer | Sale | 1.1K | $9.84 | $10.7K |
| May 22, 2025 | Steven P. Coen | Chief Accounting Officer | Sale | 346 | $7.59 | $2.6K |
| May 22, 2025 | Mark E. Dmytruk | Chief Financial Officer | Sale | 706 | $7.59 | $5.4K |
| Apr 23, 2025 | Steven P. Coen | Chief Accounting Officer | Sale | 997 | $7.28 | $7.3K |
| Apr 23, 2025 | Mark E. Dmytruk | Chief Financial Officer | Sale | 1.2K | $7.28 | $9.1K |
| Mar 6, 2025 | Steven P. Coen | Chief Accounting Officer | Sale | 395 | $7.73 | $3.1K |
| Mar 6, 2025 | Mark E. Dmytruk | Chief Financial Officer | Sale | 790 | $7.73 | $6.1K |
| Feb 6, 2025 | Steven P. Coen | Chief Accounting Officer | Sale | 367 | $13.44 | $4.9K |
| Feb 6, 2025 | Mark E. Dmytruk | Chief Financial Officer | Sale | 740 | $13.44 | $9.9K |
| Jan 8, 2025 | Steven P. Coen | Chief Accounting Officer | Sale | 324 | $11.72 | $3.8K |
Showing the 25 most recent of 357 Form 4 filings for Ginkgo Bioworks Holdings, Inc..
Most active DNA insiders
- Reshma P. Shetty89 filings
- Barry Canton88 filings
- Jason R Kelly88 filings
- Mark E. Dmytruk36 filings
- Steven P. Coen23 filings
Ask anything about DNA insider activity
Use Trabud's AI agent to query Ginkgo Bioworks Holdings, Inc.'s Form 4 history in plain English — "Show me DNA CEO purchases this year" or compare it against any other ticker.
Open the AI agentDNA insider trading FAQ
Are Ginkgo Bioworks Holdings, Inc. insiders buying or selling?
Across 357 SEC Form 4 filings, Ginkgo Bioworks Holdings, Inc. (DNA) insiders reported 4 open-market purchases totaling $1.7M and 353 sales totaling $193.3M. That is a net selling position of $191.5M.
How many insiders trade DNA stock?
10 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Ginkgo Bioworks Holdings, Inc.. The most recent filing was accepted on May 26, 2026.
Where does Trabud get DNA insider trading data?
All DNA insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.